Zevenbergen Capital Investments LLC Biomarin Pharmaceutical Inc Transaction History

Zevenbergen Capital Investments LLC

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 10, 2021	SELL	$72.61 - $90.2 $34.1 Million - $42.3 Million	-469,407 Closed	0 $0
Q3 2020 Nov 12, 2020	SELL	$71.87 - $131.03 $13.8 Million - $25.2 Million	-192,223 Reduced 29.05%	469,407 $35.7 Million
Q2 2020 Aug 12, 2020	BUY	$79.55 - $124.22 $1.47 Million - $2.3 Million	18,505 Added 2.88%	661,630 $81.6 Million
Q1 2020 May 12, 2020	SELL	$71.37 - $96.85 $43.9 Million - $59.5 Million	-614,710 Closed	0 $0
Q4 2019 Feb 07, 2020	BUY	$64.27 - $86.37 $1.57 Million - $2.1 Million	24,370 Added 4.13%	614,710 $52 Million
Q3 2019 Nov 08, 2019	SELL	$67.4 - $85.11 $3.23 Million - $4.07 Million	-47,855 Reduced 7.5%	590,340 $39.8 Million
Q2 2019 Aug 13, 2019	BUY	$80.35 - $93.9 $13.3 Million - $15.5 Million	165,445 Added 35.0%	638,195 $54.7 Million
Q1 2019 May 14, 2019	BUY	$84.2 - $98.62 $3.97 Million - $4.65 Million	47,125 Added 11.07%	472,750 $42 Million
Q4 2018 Feb 14, 2019	BUY	$80.14 - $106.07 $3.03 Million - $4 Million	37,750 Added 9.73%	425,625 $36.2 Million
Q3 2018 Nov 13, 2018	SELL	$93.92 - $105.72 $948,592 - $1.07 Million	-10,100 Reduced 2.54%	387,875 $37.6 Million
Q2 2018 Aug 14, 2018	BUY	$76.01 - $99.03 $10.1 Million - $13.2 Million	133,070 Added 50.23%	397,975 $37.5 Million
Q4 2017 Feb 14, 2018	SELL	$80.76 - $95.13 $197,054 - $232,117	-2,440 Reduced 0.91%	264,905 $23.6 Million
Q3 2017 Nov 09, 2017	BUY	$80.6 - $94.95 $21.5 Million - $25.4 Million	267,345	267,345 $24.9 Million

632

185M

1.63M

1.2M

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $13.1B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

Get notified when there are updates to the investment portfolio of Zevenbergen Capital Investments LLC, based on Form 13F filings with the SEC.

Stay updated on Zevenbergen Capital Investments LLC with notifications on news.